Deficient SOCS3 and SHP-1 expression in psoriatic T cells (Q39744026)

14 September 2017

Deficient SOCS3 and SHP-1 expression in psoriatic T cells (English)

1 reference

14 September 2017

2

1 reference

14 September 2017

4

Thorbjørn Krejsgaard

0 references

Carsten Geisler

10

Carsten Geisler

0 references

Kirsten Grønbæk

7

Kirsten Grønbaek

1 reference

14 September 2017

12

Niels Ødum

0 references

Nils Billestrup

Nils Billestrup

8

0 references

Lone Skov

Lone Skov

3

0 references

Mariusz A Wasik

11

Mariusz A Wasik

1 reference

14 September 2017

1

Karsten W Eriksen

1 reference

14 September 2017

Lone F Bovin

5

1 reference

14 September 2017

Mikkel L Hansen

6

1 reference

14 September 2017

Mogens H Nissen

9

1 reference

14 September 2017

Niels Ødum

12

1 reference

14 September 2017

language of work or name

English

0 references

publication date

4 February 2010

1 reference

Journal of Investigative Dermatology

14 September 2017

1 reference

14 September 2017

130

1 reference

14 September 2017

6

1 reference

14 September 2017

1590-1597

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.6

14 September 2017

0 references

cites work

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

The pathogenic role of tissue-resident immune cells in psoriasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

The IL-23/Th17 axis in the immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Increased Sensitivity to Interferon-α in Psoriatic T Cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Psoriasis associated with HCV and exacerbated by interferon alpha: complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Psoriasis induced by interferon-α

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Analysis of SOCS-3 promoter responses to interferon gamma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Tumor necrosis factor alpha attenuates interferon alpha signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Signaling through the JAK/STAT pathway, recent advances and future challenges

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Correlation of psoriasis activity with abundance of CD25+CD8+ T cells: conditions for cloning T cells from psoriatic plaques

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Interferon signalling network in innate defence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Negative regulation of immunoreceptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.6

7 January 2021

Identifiers

DOI

10.1038/JID.2010.6

1 reference

14 September 2017

1 reference